DRAP Warns Against Use of Fake Injection for Blood Disorders
Pakistan’s Drug Regulatory Authority (DRAP) has issued a warning against the use of counterfeit injections being circulated for treating blood disorders. Authorities highlighted that these fake medications pose serious health risks, including adverse reactions, treatment failure, and potential fatalities.
DRAP officials urged patients and healthcare providers to verify the authenticity of injections before use and to report any suspicious products immediately. The warning comes after several reports of substandard and fake drugs being detected in the market, raising concerns about patient safety and regulatory compliance.
Healthcare experts emphasized the importance of sourcing medications from licensed pharmacies and following prescribed treatment protocols. Hospitals and clinics have been instructed to increase vigilance and ensure that only certified pharmaceutical products are administered to patients.
The regulatory body also announced that investigations are underway to trace the source of these counterfeit injections, with strict penalties for offenders under existing drug laws. Public awareness campaigns are planned to educate citizens about recognizing genuine medications and avoiding potentially dangerous substitutes.
خلاصہ (اردو میں):
پاکستان کی ڈرگ ریگولیٹری اتھارٹی نے خون کے امراض کے لیے جعلی انجیکشن کے استعمال سے خبردار کیا ہے اور عوام سے درخواست کی ہے کہ صرف مستند دوائیں استعمال کریں۔
